Product Information
GLIMEPIRIDE 4 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.0518 per EA under NDC 16729000316. Its NADAC has been published 506 times since Sep 14, 2016.
The Low Outlier badge above means this manufacturer's average price in the Glimepiride market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
4 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729000316
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
5/20/2026
Active Ingredients
GLIMEPIRIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078181On Market Since
8/23/2007
Pharmacological Classes
Price Statistics
The NADAC for GLIMEPIRIDE 4 MG TABLET has been published 506 times since Sep 14, 2016, and over the history we have for it it has declined 68.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0518 per EA |
|---|---|
| All-time high | $0.1700 (Oct 12, 2016) |
| All-time low | $0.0274 (May 22, 2024) |
| 52-week high | $0.0518 |
| 52-week low | $0.0375 |
| Median price | $0.0525 |
| Average price | $0.0621 |
| Largest weekly change | +73.8% (Jun 19, 2024) |
| Weeks tracked | 506 |
| Tracking since | Sep 14, 2016 |
Generic Alternatives
The matcher finds 10 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 38% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GLIMEPIRIDE 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLIMEPIRIDE 4 MG TABLET, manufactured by Accord Healthcare Inc., is $0.0518 per EA (NDC 16729000316), effective May 20, 2026.
How has the price of GLIMEPIRIDE 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLIMEPIRIDE 4 MG TABLET has declined 68.6%. It has been tracked across 506 weekly CMS publications since Sep 14, 2016.
What are the highest and lowest recorded NADAC prices for GLIMEPIRIDE 4 MG TABLET?
Since Sep 14, 2016, the NADAC for GLIMEPIRIDE 4 MG TABLET has ranged from a low of $0.0274 (May 22, 2024) to a high of $0.1700 (Oct 12, 2016), with a median of $0.0525 per EA.
Are there cheaper alternatives to GLIMEPIRIDE 4 MG TABLET?
Yes. 10 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, GLIMEPIRIDE 4 MG TABLET, is $0.0323 per EA — about 38% below GLIMEPIRIDE 4 MG TABLET.
Who manufactures GLIMEPIRIDE 4 MG TABLET?
GLIMEPIRIDE 4 MG TABLET (NDC 16729000316) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification